Skip to Main Content

Paper Details

Defining molecular risk in ALK<sup>+</sup> NSCLC.
Oncotarget
32
2019
Author NameAffiliation
Jan BudcziesInstitute of Pathology, Heidelberg University Hospital
Martina KirchnerInstitute of Pathology, Heidelberg University Hospital
Holger S??ltmannGerman Cancer Research Center and National Center for Tumor Diseases
Albrecht StenzingerInstitute of Pathology, Heidelberg University Hospital
  • 1 - 4

Datasets

Release 1.2